Skip to main content
logo
EP Biocomposites Limited (BOM:543595)
India flag India · Delayed Price · Currency is INR
106.00
+8.99 (9.27%)
At close: Jul 29, 2026

EP Biocomposites Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
136.4136.4120.06114.3971.3180.6
Revenue Growth
16.82%13.61%4.96%60.42%-11.52%173.39%
Gross Profit
49.9249.9242.5939.1530.0930.84
Operating Income
22.7722.7717.4515.339.7213.17
Net Income
14.5814.5810.3111.55.768.09
Earnings Per Share
8.678.676.136.843.949.48
EPS Growth
58.72%41.44%-10.35%73.54%-58.44%-0.70%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
21.5421.5416.1712.721.921.56
Total Debt
23.9623.9629.7818.0212.8241.11
Net Cash (Debt)
-2.42-2.42-13.61-5.329.1-39.55
Net Cash Growth
------
Net Cash Per Share
-1.44-1.44-8.09-3.166.23-46.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
19.8919.89-4.9-12.44-7.94-42.8
Capital Expenditures
-5.87-5.87-0.21-2.36-0.22-4.74
Free Cash Flow
14.0214.02-5.11-14.8-8.17-47.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
36.60%36.60%35.47%34.22%42.19%38.26%
Operating Margin
16.70%16.70%14.53%13.40%13.63%16.34%
Pretax Margin
14.20%14.20%11.80%13.73%11.41%14.47%
Profit Margin
10.69%10.69%8.59%10.05%8.08%10.04%
FCF Margin
10.28%10.28%-4.26%-12.94%-11.45%-58.99%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
12.239.6920.1320.0658.81-
P/FCF Ratio
12.7110.07----
PS Ratio
1.311.041.732.024.75-